SCHEDULE 13D: Era Regenerative Medicine and D&D Source of Life Consolidate Majority Stake in Reed's, Inc.

Era Regenerative Medicine Ltd has become the holding company for D&D Source of Life Holding Ltd, consolidating a 59.5% beneficial ownership stake in Reed's, Inc. following a series of strategic investments totaling over $23 million.

Summary

• Era Regenerative Medicine Ltd (ERM) has become the holding company for D&D Source of Life Holding Ltd (D&D) through a restructuring on December 31, 2024.
• ERM and D&D now collectively beneficially own 27,139,519 shares of Reed's, Inc. common stock, representing 59.5% of the total class.
• The calculation of ownership percentage is based on a total of 45,603,355 shares, which includes shares outstanding as of November 21, 2024, shares issuable from warrants, and shares from a private placement on December 30, 2024.
• D&D's prior investments in Reed's, Inc. totaled $23,361,710, including a PIPE transaction in May 2023, SAFE vehicle investments in Q1 2024, a subsequent PIPE financing in September 2024, and the purchase and exchange of secured promissory notes in October/November 2024.
• The purpose of these acquisitions is for investment and business expansion, with D&D having worked with Reed's to amend bylaws to grant majority stockholder rights.

Sentiment

Score: 7

Explanation: The document indicates a significant, strategic investment and consolidation of ownership, suggesting confidence from the reporting entity in Reed's, Inc. The bylaw amendments also indicate a move towards more direct control, which can be positive for strategic alignment. While not a performance report, the substantial capital infusion and long-term investment intent are generally positive signals.

Positives

• The significant investment by D&D (over $23 million) demonstrates a strong commitment to Reed's, Inc.
• The consolidation of ownership under Era Regenerative Medicine Ltd provides a clear controlling entity, potentially streamlining strategic decisions.
• Bylaw amendments to give a majority stockholder the ability to call a stockholders meeting and other customary rights for a controlled company could lead to more efficient governance.

Future Outlook

The Reporting Persons may in the future engage in discussions with Reed's management, board of directors, and/or other stockholders or third parties covering a broad range of subjects, including performance, strategic direction, capital allocation, strategic financing opportunities or other transactions involving the Issuer, stockholder value, composition of the board of directors, and governance and/or ownership of the Issuer. The acquisitions were made for investment purposes and expansion of business.

Management Comments

• "D&D acquired the Issuer's shares, and may acquire the shares issuable upon exercise of the Issuer's warrants for investment purposes, and such purchases have been, and will be, made in D&D's ordinary course of business as an investment and for expansion of business."
• "D&D worked with the Issuer to amend the Issuer's bylaws to give a majority stockholder the ability to call a stockholders meeting and other rights reasonable and customary for operation of a controlled company."
• "Qi Meng, the sole director of ERM, has voting and dispositive power over the securities of the Issuer held directly by D&D."

Industry Context

D&D Source of Life Holding Ltd's principal business includes the production and sale of mineral water, purified water, sparkling water, beverages, and functional drinks, as well as fungal products and sugar substitute products. This aligns strategically with Reed's, Inc., a company known for its ginger beer and other beverages, suggesting a potential for synergistic business expansion or market consolidation within the beverage industry, particularly in functional or natural drink segments.

Comparison to Industry Standards

• NA. This Schedule 13D filing primarily details a change in beneficial ownership and investment history, rather than operational or financial performance metrics that would allow for direct comparison to industry standards or specific comparable companies/projects.

Corporate Governance

Related Party Transactions

• The assignment of D&D shares to ERM on December 31, 2024, for restructuring purposes without consideration, is a related party transaction between the two reporting entities.
• The various investment transactions (PIPEs, SAFE, note purchase/exchange) between D&D and Reed's, Inc. are related party transactions given D&D's significant ownership stake.

Stakeholder Impact

• Shareholders: Existing minority shareholders will now be part of a controlled company, potentially impacting their influence and the company's strategic direction. The significant investment by D&D could be seen as a vote of confidence, but also reduces the free float.
• Management/Employees: The new majority shareholder may influence strategic direction, capital allocation, and potentially board composition, which could lead to changes in company priorities or operations.
• Creditors: The exchange of secured promissory notes for equity reduces debt on the balance sheet, which could be positive for creditors.

Next Steps

• Reporting Persons may engage in further discussions with Reed's management and board regarding performance, strategic direction, capital allocation, financing, board composition, and governance.
• Potential future acquisition of shares issuable upon exercise of warrants.

Key Dates

Recommendation

Keywords

Reed's Inc., Era Regenerative Medicine, D&D Source of Life, SEC Filing, Schedule 13D, Beneficial Ownership, Majority Shareholder, Corporate Restructuring, PIPE Transaction, SAFE Vehicle, Promissory Notes, Common Stock, Investment, Beverage Industry